STAT3 suppression decreases PD-L1 expression in ALK-positive anaplastic large cell lymphoma (ALCL) [54] and KRAS-mutant non-small cell lung cancer (NSCLC) cells [55]. Here, STAT3 is linked to non-small cell lung carcinoma.